Core Scientific (CORZW) EBT (2020 - 2026)

Core Scientific's EBT history runs 7 years deep, the most recent figure standing at -$346.6 million for Q1 2026.

• In Q1 2026, EBT fell 160.12% year-over-year to -$346.6 million; the TTM figure through Mar 2026 stood at -$1.2 billion (down 13.03% YoY), while the FY2025 annual figure was -$288.0 million, up 79.96% from the prior year.
• EBT came in at -$346.6 million for Q1 2026 at Core Scientific, down from $216.1 million in the prior quarter.
• In the past five years, EBT ranged from a high of $576.5 million in Q1 2025 to a low of -$936.6 million in Q2 2025.
• A 5-year average of -$263.6 million and a median of -$290.8 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT slumped 25965.69% in 2022 and jumped 74359.51% in 2024, its largest moves.
• Core Scientific's EBT stood at -$456.3 million in 2022, then surged by 57.19% to -$195.4 million in 2023, then slumped by 48.84% to -$290.8 million in 2024, then surged by 174.3% to $216.1 million in 2025, then slumped by 260.42% to -$346.6 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$346.6 million, $216.1 million, and -$143.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison